Ardent Health (NYSE:ARDT) Stock Price Down 4.2% – Should You Sell?

Shares of Ardent Health, Inc. (NYSE:ARDTGet Free Report) were down 4.2% on Wednesday . The stock traded as low as $9.42 and last traded at $9.3930. Approximately 85,825 shares were traded during mid-day trading, a decline of 78% from the average daily volume of 394,473 shares. The stock had previously closed at $9.80.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on ARDT shares. Royal Bank Of Canada decreased their price target on Ardent Health from $14.00 to $13.00 and set an “outperform” rating for the company in a research note on Monday, March 9th. Wall Street Zen raised Ardent Health from a “hold” rating to a “buy” rating in a research note on Saturday. JPMorgan Chase & Co. decreased their price target on Ardent Health from $12.00 to $11.00 and set a “neutral” rating for the company in a research note on Tuesday, January 20th. Zacks Research raised Ardent Health from a “strong sell” rating to a “hold” rating in a research note on Wednesday, March 25th. Finally, Leerink Partners decreased their price target on Ardent Health from $16.00 to $15.00 and set an “outperform” rating for the company in a research note on Friday, March 6th. Seven investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, Ardent Health currently has a consensus rating of “Hold” and an average target price of $14.21.

View Our Latest Analysis on Ardent Health

Ardent Health Stock Down 3.2%

The firm has a 50 day moving average of $9.36 and a 200 day moving average of $9.47. The firm has a market cap of $1.36 billion, a price-to-earnings ratio of 9.98, a PEG ratio of 2.26 and a beta of 0.93. The company has a quick ratio of 2.00, a current ratio of 2.12 and a debt-to-equity ratio of 0.62.

Ardent Health (NYSE:ARDTGet Free Report) last released its earnings results on Tuesday, May 5th. The company reported $0.28 EPS for the quarter, topping the consensus estimate of $0.18 by $0.10. Ardent Health had a return on equity of 13.85% and a net margin of 2.09%.The business had revenue of $1.60 billion during the quarter, compared to analysts’ expectations of $1.58 billion. Ardent Health has set its FY 2026 guidance at 0.900-1.270 EPS. As a group, sell-side analysts predict that Ardent Health, Inc. will post 1.12 earnings per share for the current year.

Institutional Investors Weigh In On Ardent Health

Several large investors have recently added to or reduced their stakes in ARDT. Goldentree Asset Management LP grew its stake in Ardent Health by 99.7% during the fourth quarter. Goldentree Asset Management LP now owns 2,303,113 shares of the company’s stock worth $20,302,000 after purchasing an additional 1,150,000 shares during the period. Goldman Sachs Group Inc. grew its stake in Ardent Health by 1,684.9% during the first quarter. Goldman Sachs Group Inc. now owns 767,862 shares of the company’s stock worth $10,558,000 after purchasing an additional 724,841 shares during the period. Ameriprise Financial Inc. grew its stake in Ardent Health by 75.6% during the second quarter. Ameriprise Financial Inc. now owns 1,634,822 shares of the company’s stock worth $22,332,000 after purchasing an additional 703,739 shares during the period. Bridgeway Capital Management LLC grew its stake in Ardent Health by 108.2% during the fourth quarter. Bridgeway Capital Management LLC now owns 946,571 shares of the company’s stock worth $8,358,000 after purchasing an additional 491,961 shares during the period. Finally, Hotchkis & Wiley Capital Management LLC bought a new position in Ardent Health in the third quarter worth approximately $6,377,000.

Ardent Health Company Profile

(Get Free Report)

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.

Further Reading

Receive News & Ratings for Ardent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health and related companies with MarketBeat.com's FREE daily email newsletter.